We manufacture niche and complex Pharma products under the pressure of expectation
Subsidiary Accounts | Natco Pharma
Financial Report FY 2022-23
Financial Report FY 2021-22
Financial Report FY 2020-21
Financial Report FY 2019-20
Financial Report FY 2018-19
Financial Report FY 2017-18
Financial Report FY 2016-17
Financial Report FY 2015-16
Financial Report FY 2014-15
Financial Report FY 2022-23
Financial Report FY 2021-22
Financial Report FY 2020-21
Financial Report FY 2019-20
Financial Report FY 2018-19
Financial Report FY 2017-18
Financial Report FY 2016-17
Financial Report FY 2015-16
Financial Report FY 2014-15
Financial Report FY 2022-23
Financial Report FY 2021-22
Financial Report FY 2020-21
Financial Report FY 2019-20
Financial Report FY 2018-19
Financial Report FY 2018-19
Financial Report FY 2017-18
Financial Report FY 2016-17
Financial Report FY 2015-16
Financial Report FY 2014-15
Financial Report FY 2022-23
Financial Report FY 2021-22
Financial Report FY 2020-21
Financial Report FY 2019-20
Financial Report FY 2018-19
Financial Report FY 2017-18
Financial Report FY 2016-17
Financial Report FY 2015-16
Financial Report FY 2014-15
Financial Report FY 2022-23
Financial Report FY 2021-22
Financial Report FY 2020-21
Financial Report FY 2019-20
Financial Report FY 2018-19
Financial Report FY 2017-18
Financial Report FY 2016-17
Financial Report FY 2015-16
Financial Report FY 2014-15
Financial Report FY 2022-23
Financial Report FY 2021-22
Financial Report FY 2020-21
Financial Report FY 2019-20
Financial Report FY 2018-19
Financial Report FY 2022-23
Financial Report FY 2021-22
Financial Report FY 2022-23
Financial Report FY 2021-22
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
